Targeting EGFR in HPV-associated cancer

Joseph A. Sparano, Missak Haigentz, Mark H. Einstein

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.

Original languageEnglish (US)
Title of host publicationMolecular Basis for Therapy of AIDS-Defining Cancers
PublisherSpringer New York
Pages211-234
Number of pages24
ISBN (Print)9781441915122
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

Papillomaviridae
Viruses
Epidermal Growth Factor Receptor
Tumors
Hypopharynx
Neoplasms
DNA Viruses
Proto-Oncogenes
Genomic Instability
Protein Subunits
Anal Canal
Virus Diseases
Tumor Suppressor Genes
Cervix Uteri
Adenosine Triphosphatases
Squamous Cell Carcinoma
Proteins
Canals
Apoptosis
Genes

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Sparano, J. A., Haigentz, M., & Einstein, M. H. (2010). Targeting EGFR in HPV-associated cancer. In Molecular Basis for Therapy of AIDS-Defining Cancers (pp. 211-234). Springer New York. https://doi.org/10.1007/978-1-4419-1513-9_13
Sparano, Joseph A. ; Haigentz, Missak ; Einstein, Mark H. / Targeting EGFR in HPV-associated cancer. Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, 2010. pp. 211-234
@inbook{db93250cf0a64d4dbdf19f3abc9af1f3,
title = "Targeting EGFR in HPV-associated cancer",
abstract = "Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.",
author = "Sparano, {Joseph A.} and Missak Haigentz and Einstein, {Mark H.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1007/978-1-4419-1513-9_13",
language = "English (US)",
isbn = "9781441915122",
pages = "211--234",
booktitle = "Molecular Basis for Therapy of AIDS-Defining Cancers",
publisher = "Springer New York",
address = "United States",

}

Sparano, JA, Haigentz, M & Einstein, MH 2010, Targeting EGFR in HPV-associated cancer. in Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, pp. 211-234. https://doi.org/10.1007/978-1-4419-1513-9_13

Targeting EGFR in HPV-associated cancer. / Sparano, Joseph A.; Haigentz, Missak; Einstein, Mark H.

Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, 2010. p. 211-234.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Targeting EGFR in HPV-associated cancer

AU - Sparano, Joseph A.

AU - Haigentz, Missak

AU - Einstein, Mark H.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.

AB - Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.

UR - http://www.scopus.com/inward/record.url?scp=84900239716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900239716&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1513-9_13

DO - 10.1007/978-1-4419-1513-9_13

M3 - Chapter

AN - SCOPUS:84900239716

SN - 9781441915122

SP - 211

EP - 234

BT - Molecular Basis for Therapy of AIDS-Defining Cancers

PB - Springer New York

ER -

Sparano JA, Haigentz M, Einstein MH. Targeting EGFR in HPV-associated cancer. In Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York. 2010. p. 211-234 https://doi.org/10.1007/978-1-4419-1513-9_13